The Potassium Magnesium Aspartate Tablets segmentation by application delineates four primary sub‑markets: cardiovascular health, electrolyte balance, muscle function, and neurological support. The cardiovascular segment captures patients using the tablets to manage hypertension and arrhythmia, representing the largest revenue share due to the high prevalence of cardiovascular disorders and the tablets' role in stabilising cardiac electrophysiology. The electrolyte‑balance segment targets individuals with renal insufficiency or chronic diuretic therapy, where potassium‑magnesium replenishment mitigates the risk of arrhythmic events; its contribution is moderate but growing as awareness of electrolyte management expands. The muscle‑function segment serves athletes and older adults seeking to prevent cramp and fatigue, contributing a smaller yet distinct portion of sales driven by preventive health trends. Finally, the neurological‑support segment addresses patients with migraine or peripheral neuropathy, where magnesium’s NMDA‑receptor modulation offers therapeutic benefit; this niche accounts for the smallest share but demonstrates high margin potential. Collectively, these application categories define the market’s structural composition and guide resource allocation across product development, regulatory compliance, and distribution channels.
